IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Fusion Antibodies PLC - pharmaceutical company based in Belfast - Says proof-of-concept on ...

Alliance News 18 September, 2020 | 9:16PM
Email Form

Fusion Antibodies PLC - pharmaceutical company based in Belfast - Says proof-of-concept on Mammalian Antibody Library Discovery Platform, Covid-19 related research. Fusion Antibodies says "progress" being made on design of SARS-CoV-2 proteins as it looks to develop antigens to fight against virus. Stock more than doubled on Friday.

Current stock price: 222.67 pence

Year-to-date change: up sharply from 78.50p

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Fusion Antibodies PLC Ordinary Shares 147.00 GBX -6.67 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies